Even following 1,25(OH)2D3 treatment, mo-DC from MS patients display a significantly higher secretion of IL-1β, IL-6, and TNF-α following stimulation with LPS and IFN-γ as compared to 1,25(OH)2D3-treated mo-DC of healthy controls. This evidence concerns the gene IL6 and myeloid sarcoma.